In a comprehensive interview with Galaxy, Binance founder CZ shares his views on market cycles, the convergence of crypto and traditional finance, decentralization, Layer 2 vs Layer 1, Hyperliquid's innovation, prediction markets like Polymarket, and his personal investment philosophy. He believes the current cycle bottom is significantly higher than previous lows (BTC support around $60k), and industry leverage is better controlled. Crypto and TradFi will inevitably merge, with centralization and decentralization coexisting. CZ reveals Yzi Labs' investment heuristic: 70% crypto, 20% AI, 10% biotech, including investments in an artificial womb company (tested on mice, human application 5-10 years away) and knee cartilage regeneration technology (3D-printed scaffold). He also compares Chinese and US AI models, emphasizing that AI regulation is far more complex than crypto, and that the future financial system will be built collaboratively by AI, blockchain, and the internet.

In an extensive interview with Galaxy, CZ shared his macro outlook on the crypto market: the current drawdown of ~50% is normal, but each cycle's floor is higher, with historical highs (e.g., $60,000) likely acting as future support. He sees inevitable convergence between crypto and traditional finance into one fintech sector, and that centralization and decentralization will coexist indefinitely, with technology pushing toward the latter. CZ praised Hyperliquid for carving out a niche Binance cannot compete in, and backed prediction markets like Polymarket and Kalshi. He disclosed Yzi Labs' portfolio allocation: 70% crypto, 20% AI, 10% biotech, notable bets include an "artificial womb" (tested on mice, 5-10 years from human use) and a knee cartilage regeneration technology using 3D-printed scaffolds. He stressed that investment aims for impact over ROI, and warned that AI poses existential risks far greater than crypto, urging careful regulation.

In a comprehensive interview with Galaxy, Binance founder CZ shared his views on the current crypto market cycle, emphasizing higher bottoms each cycle and improved leverage control. He revealed Yzi Labs' investment framework: 70% crypto, 20% AI, 10% biotech, with specific investments in artificial womb technology (tested on mice) and 3D-printed knee cartilage regeneration. CZ discussed the inevitable convergence of traditional finance and crypto, the innovation of perpetual contracts, prediction markets, and Hyperliquid. He also contrasted AI risks (potential to destroy civilization) with crypto safety, urging careful AI regulation while noting that crypto flows will ultimately benefit from AI activity on-chain.

In a detailed interview with Galaxy, Binance founder Changpeng Zhao (CZ) shared his macro outlook on the crypto market, emphasizing that the four-year cycle continues with rising bottoms and healthier leverage among institutions. He revealed Yzi Labs' investment allocation: 70% crypto, 20% AI, 10% biotech, with bets on startups developing artificial wombs and knee cartilage regeneration. CZ also discussed the convergence of crypto and traditional finance, the role of perpetuals and prediction markets, the L1 vs L2 debate, and his belief that while AI could pose existential risks, it will ultimately rely on blockchain infrastructure.

In a Galaxy interview, CZ reviewed the current crypto market cycle, noting that Bitcoin has retraced about 50% from its all-time high but with rising bottoms, making $60,000 a key support. He predicted accelerated convergence between traditional finance and crypto, emphasizing that centralization and decentralization are not binary. CZ revealed Yzi Labs' portfolio allocation: 70% crypto, 20% AI, 10% biotech, with investments in 'artificial womb' and 'knee cartilage regeneration' projects. He also discussed prediction markets, Hyperliquid's innovation, L2 vs L1 dynamics, and AI's impact on the crypto ecosystem.

In an interview with Galaxy, Binance founder Changpeng Zhao (CZ) shared his views on the crypto market cycle, the convergence of traditional finance and crypto, centralization vs. decentralization, and prediction markets. He disclosed his personal investment allocation: approximately 70% in crypto, 20% in AI, and 10% in biotech. CZ has invested in cutting-edge projects such as an artificial womb (tested in rats, 5–10 years from human application) and a 3D-printed scaffold for knee cartilage regeneration. He criticized L2 expansion, predicted a return to L1 dominance, and warned that AI poses a greater existential risk to civilization than crypto.

In a recent interview with Galaxy, Binance founder Changpeng Zhao (CZ) shared insights on crypto market cycles, the convergence of TradFi and DeFi, prediction markets, AI development, and his personal investment philosophy. CZ believes the current cycle is healthier with rising bottoms, noting that previous highs (e.g., $60K) will serve as future support. He advocates coexistence of centralized and decentralized entities, praises Hyperliquid's innovation and prediction markets like Polymarket, and reveals Yzi Labs’ portfolio allocation: 70% crypto, 20% AI, and 10% biotech, with specific investments in artificial womb technology and knee cartilage regeneration.

In a wide-ranging interview with Galaxy, Binance founder CZ shared his outlook on crypto market cycles, leverage risks, the convergence of traditional finance and crypto, and his personal investment philosophy. CZ revealed that his family office Yzi Labs allocates 70% to crypto, 20% to AI, and 10% to biotech, having invested in an artificial womb startup and a knee cartilage regeneration technology. He also discussed the future of L2 vs L1, Hyperliquid's innovation, prediction markets, and the interplay between AI and crypto, emphasizing that crypto poses no existential threat while AI demands careful regulation.